A new initiative is set to explore the potential of repurposing existing medications to combat the symptoms of both Alzheimer’s and Parkinson’s diseases, aiming to accelerate the discovery of novel treatments.
Experts involved in the project suggest that this innovative drug development strategy could significantly reduce the waiting time for patients to access new therapies, potentially by up to a decade.
